324 related articles for article (PubMed ID: 2860126)
1. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
Katakami H; Arimura A; Frohman LA
Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
[TBL] [Abstract][Full Text] [Related]
4. Plasma growth hormone (GH) and somatomedin C response to continuous growth hormone-releasing factor (GRF) infusion in patients with GH deficiency.
Hizuka N; Takano K; Shizume K; Tanaka I; Honda N; Ling NC
Acta Endocrinol (Copenh); 1985 Sep; 110(1):17-23. PubMed ID: 2863915
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
[TBL] [Abstract][Full Text] [Related]
6. Plasma growth hormone and somatomedin-C responses to continuous growth hormone-releasing factor infusion in normal adult men.
Takano K; Honda N; Shizume K; Hizuka N; Ling NC
Endocrinol Jpn; 1985 Apr; 32(2):287-93. PubMed ID: 3930225
[TBL] [Abstract][Full Text] [Related]
7. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
Stachura ME; Tyler JM; Farmer PK
Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
[TBL] [Abstract][Full Text] [Related]
11. Alpha 2-adrenergic control of growth hormone (GH) secretion in conscious male rabbits: involvement of endogenous GH-releasing factor and somatostatin.
Minamitani N; Chihara K; Kaji H; Kodama H; Kita T; Fujita T
Endocrinology; 1989 Dec; 125(6):2839-45. PubMed ID: 2479528
[TBL] [Abstract][Full Text] [Related]
12. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
15. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
16. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
[TBL] [Abstract][Full Text] [Related]
17. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA
J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro.
Soya H; Suzuki M
Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284
[TBL] [Abstract][Full Text] [Related]
19. Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.
Davis JR; Sheppard MC; Shakespear RA; Lynch SS; Clayton RN
Clin Endocrinol (Oxf); 1986 Feb; 24(2):135-40. PubMed ID: 2871948
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
DeBell WK; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
